|
|
WAREHOUSES ESTATES BELGIUM S.C.A.
“We are building opportunities“
Information réglementée
... See more |
|
|
|
| |
|
| |
|
|
New UCB Research Showcases Value of CIMZIA® certolizumab pegol in Psoriasis and Highlights Unique Experiences and Real World Evidence for Key Patient PopulationsCIMZIA, the only Fcfree, PEGylated antiTNF, recently received marketing authorization from the European Commission for the treatment of adults with moderate to severe plaque psoriasisBrussels, Belgium – 28 June 2018 – UCB, a global... See more |
|
|
|
| |
|
| |
|
|
PRESS RELEASE:
REPURCHASE OF OWN SHARES IN THE CONTEXT OF THE LIQUIDITY CONTRACT
REGULATED INFORMATION
Wednesday 27 June 2018 – 6:00 pm CET
Repurchase of own shares in the context of... See more |
|
|
|
| |
|
| |
|
|
Antwerp, 27 June 2018, 17h45 CET
Report of the Annual General Shareholders’ Meeting
Approval of a gross dividend of EUR 2.50 per share
Today Gimv held its Annual General Meeting AGM. 38.62 % of the shares were represented
9 820 417 shares. The AGM approved the gross dividend coupon nr. 25 of EUR 2.50 per share
EUR 1.75 net.
Gimv realised a... See more |
|
|
|
| |
|
| |
|
|
goetzpartners securities Limited
MDxHealth MDXHBR: Prostate cancer test proves value in prebiopsy screening
27Jun2018 / 13:43 GMT/BST
Free to access research and investor meetings in a postMiFID2 world.
This research report is intended for use only by persons who qualify as professional investors or eligible counterparties institutional investors in the applicable jurisdiction, and not by any... | |
Search :
